Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Orthop ; 44(8): 1497-1501, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32488564

RESUMO

PURPOSE: The lockdown imposed in France to cope with the COronaVIrus Disease 2019 (COVID-19) outbreak has led to major changes in the lifestyle of French citizens. The aim of our study was to study its impact on activity related to emergencies in hand and upper limb trauma in comparison to the same reference period in 2019. MATERIAL AND METHODS: All consecutive patients consulting for upper limb injury requiring urgent care at Georges-Pompidou European Hospital (HEGP), France, during the lockdown period (case group) and the equivalent period in 2019 (control group) were included. In each group, the type of accident, the anatomical location of the injury, and the treatment were reported and compared. RESULTS: Two hundred seventy-five patients were included in the case group in comparison to 784 patients in the control group. We observed a two-third decrease in the rate of upper limb emergencies (- 64.9%) in particular a drastic drop in the rate of road, work, and leisure accidents (10.4% vs 14.3%, p = 0.1151; 10.0% vs 22.6%, p < 0.0001; 13.1% vs 30.8%, p < 0.0001, respectively), and a clear increase in domestic accidents (66.5% vs 32.3%, p < 0.0001). The aetiologies were more dominated by lacerations of soft tissues (48.4%, vs 38.3%, p = 0.0034) and infections (8.7% vs 5.1%, p = 0.0299) with an increase in the indications for surgical management (51.2% vs 36.9%, p < 0.0001). Conversely, we observed fewer consultations for joint injuries (20.7% vs 30.7%, p = 0.0015) and fractures (22.2% vs 25.9%, p = 0.2210). CONCLUSION: The lockdown imposed in France has changes the etiologies and the management of hand and upper limb emergencies.


Assuntos
Betacoronavirus , Infecções por Coronavirus , Traumatismos da Mão , Pandemias , Pneumonia Viral , Extremidade Superior/lesões , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , COVID-19 , Emergências , Feminino , França , Traumatismos da Mão/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , SARS-CoV-2 , Centros de Traumatologia , Universidades , Extremidade Superior/cirurgia , Adulto Jovem
2.
PLoS One ; 7(4): e34387, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22509296

RESUMO

UNLABELLED: Although increasing numbers of very elderly patients are requiring intensive care, few large sample studies have investigated ICU admission of very elderly patients. Data on pre triage by physicians from other specialities is limited. This observational cohort study aims at examining inter-hospital variability of ICU admission rates and its association with patients' outcomes. All patients over 80 years possibly qualifying for ICU admission who presented to the emergency departments (ED) of 15 hospitals in the Paris (France) area during a one-year period were prospectively included in the study. Main outcome measures were ICU eligibility, as assessed by the ED and ICU physicians; in-hospital mortality; and vital and functional status 6 months after the ED visit. 2646 patients (median age 86; interquartile range 83-91) were included in the study. 94% of participants completed follow-up (n = 2495). 12.4% (n = 329) of participants were deemed eligible for ICU admission by ED physicians and intensivists. The overall in-hospital and 6-month mortality rates were respectively 27.2% (n = 717) and 50.7% (n = 1264). At six months, 57.5% (n = 1433) of patients had died or had a functional deterioration. Rates of patients deemed eligible for ICU admission ranged from 5.6% to 38.8% across the participating centers, and this variability persisted after adjustment for patients' characteristics. Despite this variability, we found no association between level of ICU eligibility and either in-hospital death or six-month death or functional deterioration. In France, the likelihood that a very elderly person will be admitted to an ICU varies widely from one hospital to another. Influence of intensive care admission on patients' outcome remains unclear. TRIAL REGISTRATION: ClinicalTrials.gov NCT00912600.


Assuntos
Tomada de Decisões , Unidades de Terapia Intensiva/estatística & dados numéricos , Admissão do Paciente/estatística & dados numéricos , Idoso de 80 Anos ou mais , Serviços Médicos de Emergência/estatística & dados numéricos , Feminino , Humanos , Masculino , Triagem/estatística & dados numéricos
3.
Stroke ; 39(6): 1834-43, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18388344

RESUMO

BACKGROUND AND PURPOSE: Many patients do not receive prevention consistent with recommendations after stroke, but the relative importance of patient- and physician-related factors is uncertain. METHODS: We prospectively assessed factors associated with blood pressure (BP) <140/90 mm Hg and low-density lipoprotein (LDL) cholesterol <1 g/L in a collaborative cohort of 240 consecutive patients experiencing stroke/transient ischemic attack (Rankin <4; /=140/90 mm Hg, approximately 40% received either no treatment or one drug only, and treatment was reinforced in 20% of them only. Results were similar at 12 months with no improvement in the rate of control of risk factors. CONCLUSIONS: Therapeutic inertia is an important impediment to achieve BP and LDL control goals after stroke, even in fairly motivated/adherent patients. In-hospital initiation of preventive therapies could improve quality of secondary stroke prevention in the long term.


Assuntos
Hospitalização/estatística & dados numéricos , Hiperlipidemias/tratamento farmacológico , Hipertensão/prevenção & controle , Acidente Vascular Cerebral/prevenção & controle , Idoso , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , LDL-Colesterol/antagonistas & inibidores , LDL-Colesterol/sangue , Protocolos Clínicos , Comorbidade , Atenção à Saúde , Feminino , França/epidemiologia , Hospitalização/tendências , Hospitais/estatística & dados numéricos , Hospitais/tendências , Humanos , Hipercolesterolemia/tratamento farmacológico , Hipercolesterolemia/epidemiologia , Hipercolesterolemia/prevenção & controle , Hiperlipidemias/epidemiologia , Hiperlipidemias/fisiopatologia , Hipertensão/tratamento farmacológico , Hipertensão/epidemiologia , Hipolipemiantes/uso terapêutico , Masculino , Pessoa de Meia-Idade , Inibidores da Agregação Plaquetária/uso terapêutico , Estudos Prospectivos , Fatores de Risco , Acidente Vascular Cerebral/tratamento farmacológico , Acidente Vascular Cerebral/epidemiologia
4.
South Med J ; 96(5): 525-7, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12911198

RESUMO

Yersinia enterocolitica is a well-known cause of enterocolitis. Although focal extraintestinal manifestations and disseminated disease have been described, usually in immunosuppressed patients, infection in the chest seems to be rare. We report the case of an alcoholic man who had spontaneous pleural empyema due to Y. enterocolitica.


Assuntos
Empiema Pleural/etiologia , Empiema Pleural/microbiologia , Yersiniose/complicações , Yersiniose/microbiologia , Yersinia enterocolitica/isolamento & purificação , Yersinia enterocolitica/patogenicidade , Doença Aguda , Idoso , Empiema Pleural/terapia , Humanos , Masculino , Yersiniose/terapia
5.
Scand J Infect Dis ; 34(2): 151-3, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11928856

RESUMO

The clinical presentation of visceral leishmaniasis, or kala-azar, is variable but usually includes fever, severe cachexia, lymphadenopathy and hepatosplenomegaly. In immunocompromised patients the clinical course of the disease is even less specific and the diagnosis is often made by means of incidental detection of the parasites at atypical sites such as the gastrointestinal tract, peripheral blood, lungs and cerebrospinal fluid. We describe a case of pericardial leishmaniasis in an HIV-infected patient.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/parasitologia , Infecções por HIV/complicações , Leishmaniose Visceral/complicações , Pericardite/complicações , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Adulto , Anfotericina B/uso terapêutico , Animais , Antifúngicos/uso terapêutico , Antiprotozoários/uso terapêutico , Candida albicans/isolamento & purificação , Candidíase/complicações , Candidíase/tratamento farmacológico , Infecções por HIV/parasitologia , Humanos , Leishmania/isolamento & purificação , Leishmaniose Visceral/tratamento farmacológico , Leishmaniose Visceral/parasitologia , Masculino , Meglumina/uso terapêutico , Antimoniato de Meglumina , Compostos Organometálicos/uso terapêutico , Pericardite/tratamento farmacológico , Pericardite/parasitologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...